Nexien BioPharma, Inc. (NXEN)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 21, 2026, 4:00 PM EST
Nexien BioPharma Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Cash & Equivalents | 0.01 | 0 | 0.04 | 0.12 | 0.02 | 0.01 |
Cash & Short-Term Investments | 0.01 | 0 | 0.04 | 0.12 | 0.02 | 0.01 |
Cash Growth | -17.70% | -88.10% | -69.93% | 547.96% | 67.26% | -92.63% |
Prepaid Expenses | - | - | 0.01 | 0.01 | 0.01 | 0.01 |
Total Current Assets | 0.01 | 0 | 0.04 | 0.12 | 0.03 | 0.02 |
Total Assets | 0.01 | 0 | 0.04 | 0.12 | 0.03 | 0.02 |
Liabilities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Accounts Payable | 0.08 | 0.05 | 0.02 | 0.02 | 0.01 | 0.02 |
Accrued Expenses | - | - | - | - | - | 0 |
Short-Term Debt | 0.38 | 0.31 | 0.27 | 0.22 | 0.03 | 0.01 |
Total Current Liabilities | 0.46 | 0.37 | 0.3 | 0.24 | 0.04 | 0.03 |
Total Liabilities | 0.46 | 0.37 | 0.3 | 0.24 | 0.04 | 0.03 |
Shareholders' Equity
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 11.18 | 11.17 | 10.99 | 10.76 | 10.48 | 11.58 |
Retained Earnings | -11.64 | -11.53 | -11.3 | -10.93 | -10.31 | -8.45 |
Comprehensive Income & Other | - | - | 0.05 | 0.05 | -0.19 | -3.15 |
Shareholders' Equity | -0.45 | -0.36 | -0.25 | -0.12 | -0.01 | -0.01 |
Total Liabilities & Equity | 0.01 | 0 | 0.04 | 0.12 | 0.03 | 0.02 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Total Debt | 0.38 | 0.31 | 0.27 | 0.22 | 0.03 | 0.01 |
Net Cash (Debt) | -0.37 | -0.31 | -0.24 | -0.1 | -0.01 | -0 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Filing Date Shares Outstanding | 70.77 | 70.77 | 64.77 | 61.27 | 55.77 | 55.78 |
Total Common Shares Outstanding | 70.77 | 70.47 | 64.02 | 60.52 | 55.77 | 53.98 |
Working Capital | -0.45 | -0.36 | -0.25 | -0.12 | -0.01 | -0.01 |
Book Value Per Share | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 |
Tangible Book Value | -0.45 | -0.36 | -0.25 | -0.12 | -0.01 | -0.01 |
Tangible Book Value Per Share | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 |